Eligibility Module

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module

Ignite Creation Date: 2025-12-24 @ 3:29 PM
Ignite Modification Date: 2025-12-24 @ 3:29 PM
NCT ID: NCT00588692
Eligibility Criteria: Inclusion Criteria: * 18 years of age or greater * Cardiac Ejection Fraction (EF) greater than or equal to 25% by echocardiography within 12 months * Stable New York Heart Association (NYHA) class II or greater * Heart Failure consultation within the last 18 months * Ability to exercise on a cycle ergometer * Stable angiotensin-converting enzyme inhibitors (ACEI) or angiotensin II receptor blockers (ARB) dosage for greater than 3 months Exclusion Criteria: * Enrollment in a concurrent study that may confound the results of this study * Subjects with medical conditions that would limit study participation * Pregnancy * Brachial Systolic Blood Pressure less than 110 mmHg * Baseline AIx less than 15% * Cardiac Surgery with 60 days of potential study enrollment * Myocardial infarction within 30 days of potential study enrollment * Hemodynamically significant valvular stenosis (greater than mild) * Heart failure due to thyroid disease * Active myocarditis or anemia defined as hemoglobin less than 9 mg/dl * Presence of severe renal insufficiency with serum creatinine greater than 2.5 mg/dl * Significant pulmonary hypertension or Cor pumonale * Irregular heart rhythms * Dyspnea due to pulmonary disease * Uninterpretable echocardiographic images or radial tonometry data * Significant competing cause for exercise intolerance (e.g., severe stable angina)
Healthy Volunteers: False
Sex: ALL
Minimum Age: 18 Years
Study: NCT00588692
Study Brief:
Protocol Section: NCT00588692